DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Desai A, Karrison T, Rose B. et al.
OA08.03 Phase II trial of pembrolizumab (NCT02399371) in ireviously-treated malignant mesothelioma (MM): final analysis.
J Thorac Oncol 2018;
13: s339
DOI: 10.1016/j.jtho.2018.08.277.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.